Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients

INTRODUCTION: Sustained remission should be considered the main therapeutic target in psoriatic arthritis (PsA). Very low disease activity (VLDA) and a DAPSA score ≤ 4 are the most commonly used criteria. The aim of the present study was to evaluate the rate of sustained remission in a group of PsA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lubrano, Ennio, Perrotta, Fabio Massimo, Scriffignano, Silvia, Coates, Laura C., Helliwell, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858418/
https://www.ncbi.nlm.nih.gov/pubmed/31428989
http://dx.doi.org/10.1007/s40744-019-00171-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858418/
https://www.ncbi.nlm.nih.gov/pubmed/31428989
http://dx.doi.org/10.1007/s40744-019-00171-w

Ejemplares similares